Immunology and Microbiology
Prostate
100%
Cell Proliferation
100%
Cancer Cell
100%
Xenograft
50%
Drug Resistance
50%
Cancer Mortality
50%
Colony Formation
50%
Cell Death
50%
Protein Expression Level
50%
Transcription Factors
50%
Bioinformatics
50%
Fibrinogen
50%
Programmed Cell Death
50%
Medicine and Dentistry
Cancer Cell
100%
Prostate Cancer
100%
Enzalutamide
100%
Receptor Expression
18%
Cell Proliferation
18%
Androgen Receptor
18%
Cancer Therapy
9%
Clinical Study
9%
Cancer Mortality
9%
Xenograft
9%
Tumor Progression
9%
Programmed Cell Death
9%
Protein Expression
9%
Androgen Receptor Antagonist
9%
Tumor
9%
Colony Formation
9%
Poly ADP Ribose Polymerase
9%
Cell Death
9%
Transcription Factors
9%
Drug Resistance
9%
Metalloproteinase
9%
Fibrinogen
9%
Diseases
9%
Enzalutamide-Resistant Cell Line
9%
Pharmacology, Toxicology and Pharmaceutical Science
Enzalutamide
100%
Prostate Cancer
100%
Androgen Receptor
16%
Clinical Study
8%
Tumor Growth
8%
Cancer Mortality
8%
Androgen Receptor Antagonist
8%
Transcription Factors
8%
Drug Resistance
8%
Metalloproteinase
8%
Fibrinogen
8%
Diseases
8%